Boston Scientific celebrated a big milestone this week as FDA approved its Lotus Edge Valve, but how is the company handling recent regulatory headwinds?
Yokneam, Israel-based Rapid Medical has raised $20 million in a series C round and will use the proceeds to help complete its IDE study.
FDA’s approval of BAROnova’s TransPyloric Shuttle device comes during a time of significant shifts and changes in the obesity treatment market.
Large retailers are planting their flags in healthcare with Amazon and Best Buy leading the charge to get into the market.
Ambulatory surgery centers (ASCs) offer opportunities to improve efficiencies and outcomes--can your products play a role?
The Sunnyvale, CA-based company has long been the top dog in surgical robotics but increased competition is right around the corner for the firm.
Seeing firsthand the limitations of current overactive bladder therapies, a urogynecology surgeon invented a wearable, non-surgical solution to the problem.
In a new report, DRG experts have highlighted four medtech innovations that they see tearing up the script.
The company is bracing for a $25 million revenue hit after FDA ordered two of its mesh products off the market, but a bigger concern may be lying in wait.
The Abbott Park, IL-based has had a solid foundation of success dating back to the closure of the St. Jude Medical acquisition.
Results from the prospective, randomized, controlled, multi-surgeon clinical trial were published in Ophthalmology Glaucoma.
Johnson & Johnson’s earnings might have been down 14% when compared to last year, but the New Brunswick, NJ-based company was still able to beat analysts’ expectations.
Researchers at James Cook University in Australia found that material commonly used for fish allergy testing is unreliable.